down arrow

Arcoma AB

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0006219176
SEK
7.30
0.14 (1.96%)

Dec 04

OME

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Glycorex Transplantation AB
Acarix AB
Arcoma AB
Redsense Medical AB
Episurf Medical AB
Clinical Laserthermia Systems AB
Dignitana AB
AroCell AB
Ziccum AB
SciBase Holding AB
Irras AB
Why is Arcoma AB ?
1
The company has declared negative results in Dec'2024 after 6 consecutive positive quarters
  • NET SALES(HY) At SEK 71.68 MM has Grown at -26.7%
  • INVENTORY TURNOVER RATIO(HY) Lowest at 4.5%
  • DEBTORS TURNOVER RATIO(HY) Lowest at 4.61%
2
Below par performance in long term as well as near term
  • Along with generating -32.51% returns in the last 1 year, the stock has also underperformed OMX Stockholm 30 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Arcoma AB for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
Arcoma AB
-33.33%
-1.42
37.58%
OMX Stockholm 30
8.01%
0.51
18.11%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
1.73%
EBIT Growth (5y)
-3.00%
EBIT to Interest (avg)
3.04
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.13
Sales to Capital Employed (avg)
2.72
Tax Ratio
26.39%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
11.35%
ROE (avg)
6.76%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
2.14
EV to EBIT
10.70
EV to EBITDA
6.32
EV to Capital Employed
2.51
EV to Sales
0.87
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
23.44%
ROE (Latest)
8.26%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Bearish
Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

RAW MATERIAL COST(Y)

Fallen by 0.55% (YoY

CASH AND EQV(HY)

Highest at SEK 21.57 MM

OPERATING PROFIT MARGIN(Q)

Highest at 16.27 %

-16What is not working for the Company
NET SALES(HY)

At SEK 71.68 MM has Grown at -26.7%

INVENTORY TURNOVER RATIO(HY)

Lowest at 4.5%

DEBTORS TURNOVER RATIO(HY)

Lowest at 4.61%

PRE-TAX PROFIT(Q)

At SEK 2.58 MM has Fallen at -24.99%

NET PROFIT(Q)

At SEK 2.04 MM has Fallen at -26.87%

Here's what is working for Arcoma AB
Operating Profit Margin
Highest at 16.27 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Cash and Eqv
Highest at SEK 21.57 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by 0.55% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Arcoma AB
Net Sales
At SEK 71.68 MM has Grown at -26.7%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (SEK MM)

Pre-Tax Profit
At SEK 2.58 MM has Fallen at -24.99%
over average net sales of the previous four periods of SEK 3.44 MM
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (SEK MM)

Net Profit
At SEK 2.04 MM has Fallen at -26.87%
over average net sales of the previous four periods of SEK 2.79 MM
MOJO Watch
Near term Net Profit trend is negative

Net Profit (SEK MM)

Inventory Turnover Ratio
Lowest at 4.5%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio
Lowest at 4.61%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."